Medicine guide
Ogivri
420 mg/20mL · Injection, Powder, Lyophilized, for Solution
- Prescription only
- HER2/neu Receptor Antagonist
- Active substance
- Trastuzumab-Dkst
- Made by
- Biocon Biologics Inc.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Biocon Biologics Inc. |
|---|---|
| Active substance | Trastuzumab-Dkst |
| Strength | 420 mg/20mL |
| Form | Injection, Powder, Lyophilized, for Solution |
| Route | Intravenous |
| NDC | 83257-003 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
5 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Injection, Powder, Lyophilized, for Solution3 products
150 mg/7.4mL2
150 mg/7.4mL · 2 companies
- 420 mg/20mL
- Kit2 products
—2
— · 2 companies
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.